WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) have issued a draft guidance document titled "Considerations for Including Tissue Biopsies in Clinical Trials." This guidance is designed to aid industry professionals, clinical investigators, institutions, and institutional review boards (IRBs) in understanding best practices for conducting tissue biopsies in adults and children participating in clinical trials.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products